Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cybin Inc N.CYBN

Alternate Symbol(s):  CYBN

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary... see more

NEO:CYBN - Post Discussion

Cybin Inc > CyBin Acquisition
View:
Post by Jim1274 on Dec 08, 2020 11:21am

CyBin Acquisition

So did Cybin actually just manage to buy a company with multiple patents and years of intellectual property for 6million shares?? Then an additional 6m shares “IF” they meet expectations..?? Sounds like a crazy deal and a good way to insure the team works their toushies off to get this thing done!! Opinions?? Did I miss something??
Comment by realitycheck00 on Dec 09, 2020 11:05am
Dont think the market has even priced in this deal yet.  Not a scientist by any means but looking at deuterated molecules does position Cybin leaps and bounds past competitors as all molecules become truly novel. With the 1 patent they already had now they are at 7 patent filings and a crazy upgrade to the science team.  Looking through the acquisition deck it seems the team has vast ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities